Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zicam Cold & Flu Relief is a homeopathic over-the-counter (OTC) product developed and distributed by Church & Dwight. It is formulated as quick-dissolve tablets containing a combination of active ingredients: zinc acetate, zinc gluconate, *Echinacea angustifolia*, and *Sambucus nigra* (elderberry). The product is marketed to temporarily relieve symptoms associated with the common cold and flu, including cough, sore throat, chest congestion, hoarseness, body aches, fever, and chills. While the zinc components are traditionally intended to reduce the duration of the common cold, the herbal components are included based on homeopathic practices. It is important to note that these claims are based on traditional homeopathic practice and are not supported by accepted medical evidence; the product has not been evaluated by the FDA for safety or efficacy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zicam Cold & Flu Relief.